Editors' ChoiceMetabolic Disease

Targeting NASH with OxPL neutralization

See allHide authors and affiliations

Science Translational Medicine  18 Dec 2019:
Vol. 11, Issue 523, eaaz9770
DOI: 10.1126/scitranslmed.aaz9770

Abstract

Accumulation of oxidized phospholipids (OxPLs) contribute to NASH development.

View Full Text

Stay Connected to Science Translational Medicine